APA

Suh N., Glasebrook A. L., Palkowitz A. D., Bryant H. U., Burris L. L., Starling J. J., Pearce H. L., Williams C., Peer C., Wang Y. & Sporn M. B. (20020103). Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer. : Cancer research.

Chicago

Suh N, Glasebrook A L, Palkowitz A D, Bryant H U, Burris L L, Starling J J, Pearce H L, Williams C, Peer C, Wang Y and Sporn M B. 20020103. Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer. : Cancer research.

Harvard

Suh N., Glasebrook A. L., Palkowitz A. D., Bryant H. U., Burris L. L., Starling J. J., Pearce H. L., Williams C., Peer C., Wang Y. and Sporn M. B. (20020103). Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer. : Cancer research.

MLA

Suh N, Glasebrook A L, Palkowitz A D, Bryant H U, Burris L L, Starling J J, Pearce H L, Williams C, Peer C, Wang Y and Sporn M B. Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer. : Cancer research. 20020103.